SG

Sonal Gambhir

Active Director Director DIN 08761587
DIN 08761587 First appointment Jun 2020 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2020
Shareholding value •••• Premium profile

About Sonal Gambhir

Data last updated:

Sonal Gambhir is a Director at Edelroche Life Sciences Private Limited (since 2020). The company operates in Chemicals. Edelroche Life Sciences Private Limited reported revenue of ₹20.1 Lakh (FY 2024).

DIN 08761587
Primary Designation Director
Industry Chemicals
First Appointment 11 Jun 2020
Oldest Company Age 7 yrs
Largest company Edelroche Life Sciences Private Limited · ₹20.1 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Jun 20202019₹20.1 Lakh (FY 2024)Active

Board colleagues of Sonal Gambhir

Directorship timeline

Open interactive timeline →
Edelroche Life Sciences Private Limited
Premium access

Shareholding and investment profile for Sonal Gambhir

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sonal Gambhir

Sonal Gambhir currently holds 1 directorship: Edelroche Life Sciences Private Limited (Director, since 11 Jun 2020, revenue ₹20.1 Lakh (FY 2024)).

Sonal Gambhir was first appointed on 11 Jun 2020 as Director at Edelroche Life Sciences Private Limited.

The current boards of Sonal Gambhir's companies include Shashank Rastogi (Edelroche Life Sciences Private Limited), Vinay Gambhir (Edelroche Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available